Hudock Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-90
| Closed | -$61K | – | 588 |
|
|
2022
Q3 | $61K | Hold |
90
| – | – | 0.02% | 274 |
|
|
2022
Q2 | $53K | Hold |
90
| – | – | 0.02% | 294 |
|
|
2022
Q1 | $62K | Hold |
90
| – | – | 0.02% | 295 |
|
|
2021
Q4 | $56K | Hold |
90
| – | – | 0.02% | 315 |
|
|
2021
Q3 | $54K | Hold |
90
| – | – | 0.02% | 309 |
|
|
2021
Q2 | $50K | Hold |
90
| – | – | 0.01% | 320 |
|
|
2021
Q1 | $42K | Hold |
90
| – | – | 0.01% | 338 |
|
|
2020
Q4 | $43K | Hold |
90
| – | – | 0.01% | 318 |
|
|
2020
Q3 | $50K | Hold |
90
| – | – | 0.02% | 275 |
|
|
2020
Q2 | $56K | Hold |
90
| – | – | 0.02% | 254 |
|
|
2020
Q1 | $43K | Hold |
90
| – | – | 0.02% | 245 |
|
|
2019
Q4 | $33K | Hold |
90
| – | – | 0.01% | 289 |
|
|
2019
Q3 | $24K | Hold |
90
| – | – | 0.01% | 326 |
|
|
2019
Q2 | $28K | Hold |
90
| – | – | 0.01% | 307 |
|
|
2019
Q1 | $36K | Hold |
90
| – | – | 0.01% | 277 |
|
|
2018
Q4 | $32K | Hold |
90
| – | – | 0.01% | 275 |
|
|
2018
Q3 | $36K | Hold |
90
| – | – | 0.01% | 283 |
|
|
2018
Q2 | $31K | Hold |
90
| – | – | 0.01% | 285 |
|
|
2018
Q1 | $30K | Hold |
90
| – | – | 0.01% | 302 |
|
|
2017
Q4 | $33K | Hold |
90
| – | – | 0.01% | 289 |
|
|
2017
Q3 | $40K | Hold |
90
| – | – | 0.02% | 266 |
|
|
2017
Q2 | $44K | Hold |
90
| – | – | 0.02% | 243 |
|
|
2017
Q1 | $34K | Hold |
90
| – | – | 0.02% | 267 |
|
|
2016
Q4 | $33K | Hold |
90
| – | – | 0.02% | 265 |
|
|
2016
Q3 | $36K | Sell |
90
-50
| -36% | -$20.1K | 0.02% | 262 |
|
|
2016
Q2 | $48K | Buy |
140
+50
| +56% | +$19.3K | 0.03% | 235 |
|
|
2016
Q1 | $32K | Hold |
90
| – | – | 0.02% | 283 |
|
|
2015
Q4 | $48K | Hold |
90
| – | – | 0.02% | 216 |
|
|
2015
Q3 | $41K | Hold |
90
| – | – | 0.02% | 236 |
|
|
2015
Q2 | $45K | Hold |
90
| – | – | 0.02% | 222 |
|
|
2015
Q1 | $41K | Hold |
90
| – | – | 0.02% | 245 |
|
|
2014
Q4 | $37K | Hold |
90
| – | – | 0.02% | 242 |
|
|
2014
Q3 | $32K | Sell |
90
-75
| -45% | -$25.1K | 0.02% | 261 |
|
|
2014
Q2 | $47K | Buy |
+165
| New | +$48.9K | 0.05% | 215 |
|
Other funds holding REGN
Hudock Inc's REGN Position: Q4 2022 in Review
Hudock Inc sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 90 shares — an estimated $61K sold.
Hudock Inc first reported a position in REGN in Q2 2014 and held it in 34 quarters. The position peaked at $62K in Q1 2022. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.
- Hudock Inc reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Hudock Inc sold 90 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $61K.
- Hudock Inc first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 34 quarters.
- Hudock Inc's Regeneron Pharmaceuticals position peaked at $62K in Q1 2022.
- 1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.
Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.